During the past decade, Melbourne Brain Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Melbourne Brain Centre" #1 collaborator was "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Melbourne Brain Centre" are "Dravet Syndrome" (2 trials), "Lennox Gastaut Syndrome" (2 trials), "Epileptic Encephalopathy" (1 trials), "Glucose Transporter Type 1 Deficiency Syndrome" (1 trials) and "Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)" (1 trials). Many other conditions were trialed in "Melbourne Brain Centre" in a lesser frequency.

Most popular intervention types in "Melbourne Brain Centre" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "UX007" (2 trials), "ZX008 (Fenfluramine Hydrochloride)" (2 trials), "Matching Placebo" (1 trials), "Placebo" (1 trials) and "ZX008 0.2 or 0.8 mg/kg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Melbourne Brain Centre" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Melbourne Brain Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Melbourne Brain Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Melbourne Brain Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".